Ipsen Biopharmaceuticals is a mid-sized global biopharmaceutical company dedicated to developing transformative medicines in Oncology, Rare Disease, and Neuroscience. With nearly 100 years of experience, Ipsen operates from global hubs in the U.S., France, and the U.K., focusing on addressing high unmet medical needs through innovative research. The company is committed to fostering a human-centric workplace culture that emphasizes collaboration, excellence, and impact, empowering employees to thrive alongside the company's growth. Ipsen's passionate teams work across more than 40 countries to deliver medicines to patients in 88 countries, making a significant difference in patients' lives and society as a whole.